Bohrmann; Bernd
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bohrmann; Bernd.The latest application filed is for "humanized anti-tau(ps422) antibodies and methods of use".
- Bohrmann; Bernd - Riehen CH
- - Riehen CH
- Bohrmann; Bernd - Basel CH
- Bohrmann; Bernd - Freiburg DE
| Patent | Date |
|---|---|
| Humanized Anti-tau(ps422) Antibodies And Methods Of Use App 20200223912 - Grueninger; Fiona ; et al. | 2020-07-16 |
| Humanized anti-Tau(pS422) antibodies and methods of use Grant 10,465,000 - Grueninger , et al. No | 2019-11-05 |
| Blood Brain Barrier Shuttle App 20190276530 - Bohrmann; Bernd ; et al. | 2019-09-12 |
| Humanized anti-Tau(pS422) antibodies and methods of use Grant 10308710 - | 2019-06-04 |
| METHOD AND CONSTRUCTS FOR THE pH DEPENDENT PASSAGE OF THE BLOOD-BRAIN-BARRIER App 20170174776 - Bohrmann; Bernd ; et al. | 2017-06-22 |
| HUMANIZED ANTI-Tau(pS422) ANTIBODIES AND METHODS OF USE App 20170129949 - Grueninger; Fiona ; et al. | 2017-05-11 |
| Humanized anti-Tau(pS422) antibodies and methods of use Grant 9,562,091 - Grueninger , et al. February 7, 2 | 2017-02-07 |
| Therapeutic Fusion Protein App 20160168253 - Bohrmann; Bernd ; et al. | 2016-06-16 |
| Use of an anti-Tau pS422 antibody for the treatment of brain diseases Grant 9,290,567 - Bohrmann , et al. March 22, 2 | 2016-03-22 |
| Antibodies against amyloid beta 4 with glycosylation in the variable region Grant 9,272,031 - Loetscher , et al. March 1, 2 | 2016-03-01 |
| Blood Brain Barrier Shuttle App 20150322149 - Bohrmann; Bernd ; et al. | 2015-11-12 |
| HUMANIZED ANTI-Tau(pS422) ANTIBODIES AND METHODS OF USE App 20150175685 - Grueninger; Fiona ; et al. | 2015-06-25 |
| Antibodies Against Amyloid Beta 4 With Glycosylation In The Variable Region App 20150165022 - LOETSCHER; Hansruedi ; et al. | 2015-06-18 |
| Antibodies against amyloid beta 4 with glycosylation in the variable region Grant 8,906,370 - Loetscher , et al. December 9, 2 | 2014-12-09 |
| Use of an anti-Tau pS422 antibody for the treatment of brain diseases Grant 8,609,097 - Bohrmann , et al. December 17, 2 | 2013-12-17 |
| Use Of An Anti-tau Ps422 Antibody For The Treatment Of Brain Diseases App 20130310541 - Bohrmann; Bernd ; et al. | 2013-11-21 |
| Anti-amyloid Beta Antibodies And Their Use App 20130136747 - BARDROFF; Michael ; et al. | 2013-05-30 |
| Nucleic acid molecules encoding anti-amyloid beta antibodies Grant 8,329,886 - Bardroff , et al. December 11, 2 | 2012-12-11 |
| Method and Constructs for the pH Dependent Passage of the Blood-brain-barrier App 20120282176 - Bohrmann; Bernd ; et al. | 2012-11-08 |
| Anti-amyloid Beta Antibodies And Their Use App 20120225478 - Bardroff; Michael ; et al. | 2012-09-06 |
| Anti-A.beta. antibodies and their use Grant 8,216,577 - Bardroff , et al. July 10, 2 | 2012-07-10 |
| Use Of An Anti-tau Ps422 Antibody For The Treatment Of Brain Diseases App 20110059093 - Bohrmann; Bernd ; et al. | 2011-03-10 |
| Quadruple Transgenic Non-human Animal App 20100306868 - Bohrmann; Bernd ; et al. | 2010-12-02 |
| Anti-amyloid .beta. antibodies Grant 7,794,719 - Bardroff , et al. September 14, 2 | 2010-09-14 |
| Anti-Abeta antibodies and their use App 20100172907 - Bardroff; Michael ; et al. | 2010-07-08 |
| Antibodies Against Amyloid Beta 4 With Glycosylated in the Variable Region App 20090252724 - Loetscher; Hansruedi ; et al. | 2009-10-08 |
| Antibody that recognizes phosphorylated peptides App 20070280935 - Bohrmann; Bernd ; et al. | 2007-12-06 |
| Anti-amyloid beta antibodies and their use App 20050169925 - Bardroff, Michael ; et al. | 2005-08-04 |
| Quantification of beta amyloid App 20040096907 - Bohrmann, Bernd ; et al. | 2004-05-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 